The Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management

Pain Clinical Trial

Official title:

To Evaluate the Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management; Multicenter, Cross-sectional Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01829828
• Other study ID #: CR100835
• Secondary ID: FENPAI4097FEN-KO
• Status: Completed
• Phase: Phase 4
• First received: April 8, 2013
• Last updated: April 8, 2013
• Start date: January 2012
• Est. completion date: May 2012

Study information

• Verified date: April 2013
• Source: Janssen Korea, Ltd., Korea
• Contact: n/a
• Is FDA regulated: No
• Health authority: Korea: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this survey is to investigate the usefulness of a patient self-reported scoring tool on patient satisfaction improvement.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 587
• Est. completion date: May 2012
• Est. primary completion date: May 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients who have no experience with the study self-reported pain scoring tool

• Patients who are able to understand and answer the pain scoring tool questions

• Patients admitted to a hospital for more than 5 days due to cancer pain

• Patients for whom their pain managing physicians completed the medical staff's survey

Exclusion Criteria:

• Patients who cannot answer the questions due to cognitive impairments

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Pain

Intervention

Behavioral:
• No intervention
This is an observational study with no investigational drug administered.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Janssen Korea, Ltd., Korea

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient satisfaction with the control of cancer-related pain	Patients will answer on a 7-point scale how satisfied they feel about their cancer pain treatment. The scale scores range from 1 (not at all satisfied) to 7 (very much satisfied).	At baseline	No
Secondary	Patient perception of pain	Patients will answer on an 11-point scale how much pain they feel. The scales scores range from 0 (no pain at all) to 10 (pain as bad as you can imagine).	At baseline	No
Secondary	Patient pain assessment by medical staff	The patient's physician will mark on an 11-point scale the intensity of the patient pain. The scale scores range from 0 (no pain at all) to 10 (pain as bad as you can imagine).	At baseline	No

External Links

•   To learn how to participate in this trial please click here.